Ms. Deanna Lynn Twait, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6960 S 110th St, La Vista, NE 68128 Phone: 402-597-4990 |
Michelle Reilly Lanoue Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7900 Edgewood Blvd, La Vista, NE 68128 Phone: 402-898-0436 |
Mrs. Kendra Kay Speece, .M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8541 S 99th Cir, La Vista, NE 68128 Phone: 402-658-8627 |
Erica Smith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7609 S 89th St, La Vista, NE 68128 Phone: 402-898-0433 |
Madeline Clauson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7600 S 72nd St, La Vista, NE 68128 Phone: 402-517-8012 |
Andrea Berry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8009 S 67th Street Cir, La Vista, NE 68128 Phone: 816-863-8868 |
Madison Kae Weinberger, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7821 Terry Dr, La Vista, NE 68128 Phone: 402-992-4897 |
Rachel Lynn Lee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7600 S 72nd St, La Vista, NE 68128 Phone: 402-898-0455 |
Kristin Bender Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6960 S 110th St, La Vista, NE 68128 Phone: 402-597-4990 |
Jasmin Kunz, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7821 Terry Dr, La Vista, NE 68128 Phone: 402-898-0463 |
News Archive
Each year, approximately 1.8 million women will have a cesarean delivery or hysterectomy. While opioids are the mainstay treatment for acute pain after these surgeries, most women use only a fraction of the opioids prescribed and do not properly dispose of unused drugs
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
Media outlets report on a range of health law issues, including the latest estimates from the Department of Health and Human Services regarding the number of Medicare beneficiaries getting free preventive care, what difficulties may be ahead for health exchanges and the adminstration's new "Enroll America" campaign.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
› Verified 8 days ago